Security Snapshot

Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST) Institutional Ownership

CUSIP: 59935V107

13F Institutional Holders and Ownership History from Q2 2019 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

78

Shares (Excl. Options)

49.55MFull value: 49,554,243 · shares · 30 Jun 2026

Price

$1.34

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Shares, no par value
Symbol
MIST on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
49,554,243
Latest holder snapshot 5 signals
Total 13F value
$66,401,637
Portfolio coverage rank
0%
Share change
+10,059,431
Value change
+$13,835,696
Number of holders
78
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
124,217,096
SEC-reported price per share
$0.87
Insider filing price
$0.87
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value is tracked under CUSIP 59935V107.
  • 78 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 87 to 78 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $47.22MFull value: $47,216,565 · USD · 31 Mar 2026
    to
    $66.4MFull value: $66,401,637 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 78 institutions filings for Q2 2026.

Open SEC evidence

Security key

59935V107

13F reference period

Q2 2026

13F holders

78

13D/G owners

6

CIK / CUSIP context first

Open Q2 2026 holders MIST full holder history Milestone Pharmaceuticals Inc. SEC filings Milestone Pharmaceuticals Inc. company facts Milestone Pharmaceuticals Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
MIST
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.9% 0% $24,713,906 +$6,403,570 12,356,953 +35% RTW Investments, LP 31 Mar 2026
Pavaki Capital Management LLC 7.3% $11,878,881 9,067,848 Pavaki Capital Management LLC 31 Dec 2025
Propel Bio Management, LLC 9.9% $21,001,011 8,861,186 Propel Bio Management, LLC 11 Jul 2025
Adage Capital Management, L.P. 6.4% -36% $16,000,000 -$1,318,128 8,000,000 -7.6% Adage Capital Management, L.P. 31 Mar 2026
Trails Edge Capital Partners, LP 4.3% -56% $9,013,333 -$6,226,884 5,333,333 -41% Trails Edge Capital Partners, LP 20 Mar 2026
INTEGRATED CORE STRATEGIES (US) LLC 0.6% $396,161 322,082 Integrated Core Strategies (US) LLC 31 Mar 2025
As of 30 Jun 2026, 78 institutional investors reported holding
49.55MFull value: 49,554,243 · shares · 30 Jun 2026
shares of Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST). This represents 40% of the company’s total
124.22MFull value: 124,217,096 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
39%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Pavaki Capital Management LLC 7.3% 9,067,848 +0.06% 6.9% $12,150,916
RTW INVESTMENTS, LP 6.3% 7,833,336 +24% 0.09% $10,496,670
Propel Bio Management, LLC 6% 7,429,590 +80% 5.2% $9,955,651
Point72 Asset Management, L.P. 4.4% 5,411,138 +398% 0.01% $7,250,925
Simplify Asset Management Inc. 2.7% 3,349,379 +122% 0.06% $4,488,168
MILLENNIUM MANAGEMENT LLC 2.5% 3,142,219 +103% 0% $4,210,573
TWO SIGMA INVESTMENTS, LP 1.6% 2,040,015 -12% 0% $2,733,620
MARSHALL WACE, LLP 1.4% 1,797,695 -7.6% 0% $2,408,911
Kalehua Capital Management LLC 1% 1,269,237 0.98% $1,700,778
Lion Point Capital, LP 0.66% 820,000 0% 5.3% $1,098,800
TORONTO DOMINION BANK 0.6% 750,000 0% 0% $1,005,000
AMERIPRISE FINANCIAL INC 0.54% 666,666 0% 0% $893,332
Boxer Capital Management, LLC 0.54% 666,666 0% 0.07% $893,332
MORGAN STANLEY 0.51% 635,211 -12% 0% $851,183
UBS Group AG 0.37% 465,403 -6% 0% $623,641
BOOTHBAY FUND MANAGEMENT, LLC 0.37% 462,669 +174% 0.01% $619,976
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.29% 359,895 -31% 0% $482,259
Aptus Capital Advisors, LLC 0.27% 339,450 +21% 0% $454,863
GUARDIAN WEALTH ADVISORS, LLC / NC 0.27% 339,450 +21% 0.03% $454,863
Seven Fleet Capital Management LP 0.22% 270,233 -19% 0.06% $362,112
Squarepoint Ops LLC 0.19% 231,824 -31% 0% $310,644
LPL Financial LLC 0.18% 220,873 +14% 0% $295,970
Balyasny Asset Management L.P. 0.18% 220,498 -74% 0% $295,467
BNP PARIBAS FINANCIAL MARKETS 0.14% 173,704 0% 0% $232,763
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC 0.12% 150,000 +50% 0.11% $201,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
30
Headline period
Q2 2026
Rows shown
1-25 of 30
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 14,134,545 $12,236,277 +$1,318,236 $0.87 10
2026 Q2 49,554,243 $66,401,637 +$13,835,696 $1.34 78
2026 Q1 39,527,612 $47,216,565 +$1,536,619 $1.19 87
2025 Q4 26,494,301 $53,565,472 -$15,312,984 $2.02 79
2025 Q3 34,138,461 $68,276,752 +$44,826,873 $2.00 61
2025 Q2 11,817,806 $22,925,663 +$893,027 $1.94 43
2025 Q1 11,824,370 $9,461,152 -$26,033,743 $0.80 43
2024 Q4 24,552,580 $57,943,143 -$9,780,800 $2.36 46
2024 Q3 28,677,385 $43,589,418 -$2,288,268 $1.52 41
2024 Q2 30,178,631 $39,890,373 -$1,767,212 $1.32 39
2024 Q1 31,068,273 $55,610,121 +$23,911,141 $1.79 40
2023 Q4 17,804,637 $29,733,304 -$3,789,133 $1.67 40
2023 Q3 19,572,198 $60,672,803 -$3,310,719 $3.10 39
2023 Q2 20,687,365 $58,958,957 -$3,141,348 $2.85 48
2023 Q1 21,710,779 $85,540,237 -$9,705,873 $3.94 49
2022 Q4 23,737,827 $94,006,246 -$28,853,317 $3.96 55
2022 Q3 20,398,285 $187,452,026 +$10,127,011 $9.19 43
2022 Q2 20,825,690 $127,165,640 -$2,809,102 $6.15 29
2022 Q1 21,048,124 $135,124,913 +$5,027,454 $6.42 28
2021 Q4 20,243,658 $132,596,706 +$1,818,999 $6.55 27
2021 Q3 19,956,009 $113,947,594 -$1,093,248 $5.71 26
2021 Q2 20,148,798 $110,818,750 -$885,245 $5.50 26
2021 Q1 20,284,874 $117,447,374 -$1,995,259 $5.79 31
2020 Q4 20,571,334 $137,829,226 +$33,967,631 $6.70 33
2020 Q3 15,483,607 $113,344,014 +$42,783,062 $7.32 29
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .